肝细胞癌代谢组学：从生物标志物发现到精准医学（Table1文档）
肝细胞癌代谢组学综述Table1文档，汇总HCC代谢改变、代谢物生物标志物及多组学精准医学应用与挑战。
基本信息
资源简介
肝细胞癌代谢组学：从生物标志物发现到精准医学（Table1文档）
【一句话概览】
本数据集是 figshare 公开的文本数据集，收录 1 个文件、合计 25.54 KB，主题涵盖 hepatocellular carcinoma、metabolomics、precision medicine、biomarkers、multi-omics，可用于医学自然语言处理（实体识别、信息抽取等），CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Table1_Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine.docx》。配套论文《Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective》发表于 Journal of Personalized Medicine（2022），DOI：10.3390/jpm12020149。源站首次发布：2023-01-04。
【数据内容】
源站原始描述：Hepatocellular carcinoma (HCC) remains a global health burden, and is mostly diagnosed at late and advanced stages. Currently, limited and insensitive diagnostic modalities continue to be the bottleneck of effective and tailored therapy for HCC patients. Moreover, the complex reprogramming of metabolic patterns during HCC initiation and progression has been obstructing the precision medicine in clinical practice. As a noninvasive and global screening approach, metabolomics serves as a powerful t…
【数据结构与技术规格】
文件数 1 个，合计 25.54 KB。Table1_Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine.docx：application/vnd.openxmlformats-officedocument.wordprocessingml.document，25.54 KB。数据集 DOI：10.3389/fmedt.2022.1065506.s001。
【主题与分类】
源站学科分类：Medical Biotechnology Diagnostics (incl. Biosensors)、Regenerative Medicine (incl. Stem Cells and Tissue Engineering)、Biotechnology、Medical Devices、Biomedical Engineering not elsewhere classified。主题标签：hepatocellular carcinoma、metabolomics、precision medicine、biomarkers、multi-omics。
【适用方向】
文本类数据可用于医学自然语言处理，如命名实体识别、信息抽取与文本分类。
【获取与许可】
源站页面：https://frontiersin.figshare.com/articles/dataset/Table1_Metabolomics_in_hepatocellular_carcinoma_From_biomarker_discovery_to_precision_medicine_docx/21811812
使用许可：CC BY 4.0（https://creativecommons.org/licenses/by/4.0/）。
规范引用：Wu, Xingyun; Wang, Zihao; Luo, Li; Shu, Dan; Wang, Kui (2023). Table1_Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine.docx. Frontiers. Dataset
【使用注意】
· 源站最后修改于 2023-06-05，引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载，适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档，适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务（收技术服务费，非数据销售）
暂未开放当前数据集主要来源为 Kaggle 公开托管，完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取（Figshare）
- 源站标题：Table1_Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine.docx
- DOI：10.3389/fmedt.2022.1065506.s001
- 发布日期：2023-01-04
- 文件数：1 个
- 文件总体积：25.54 KB
- 源站页面：https://frontiersin.figshare.com/articles/dataset/Table1_Metabolomics_in_hepatocellular_carcinoma_From_biomarker_discovery_to_precision_medicine_docx/21811812
命令行下载
curl -L -o "Table1_Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine.docx" "https://ndownloader.figshare.com/files/38702532"
文件清单
Table1_Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine.docx（25.54 KB）
文件总体积 25.54 KB（源站 API 实测）。
数据说明
Hepatocellular carcinoma (HCC) remains a global health burden, and is mostly diagnosed at late and advanced stages. Currently, limited and insensitive diagnostic modalities continue to be the bottleneck of effective and tailored therapy for HCC patients. Moreover, the complex reprogramming of metabolic patterns during HCC initiation and progression has been obstructing the precision medicine in clinical practice. As a noninvasive and global screening approach, metabolomics serves as a powerful tool to dynamically monitor metabolic patterns and identify promising metabolite biomarkers, therefore holds a great potential for the development of tailored therapy for HCC patients. In this review, we summarize the recent advances in HCC metabolomics studies, including metabolic alterations associated with HCC progression, as well as novel metabolite biomarkers for HCC diagnosis, monitor, and prognostic evaluation. Moreover, we highlight the application of multi-omics strategies containing metabolomics in biomarker discovery for HCC. Notably, we also discuss the opportunities and challenges of metabolomics in nowadays HCC precision medicine. As technologies improving and metabolite biomarkers discovering, metabolomics has made a major step toward more timely and effective precision medicine for HCC patients.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/fmedt.2022.1065506.s001（source: https://frontiersin.figshare.com/articles/dataset/Table1_Metabolomics_in_hepatocellular_carcinoma_From_biomarker_discovery_to_precision_medicine_docx/21811812）。
数据缺失？
依托陕西、四川两大基地，我们与超过十家三甲医院建立直接合作关系，覆盖合规授权、采集治理、专业标注、数据交付的全流程，为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务？立即联系我们获取专业方案。
